Cancer Therapy Market Report 2026

Cancer Therapy Market Overview

• Cancer Therapy market size has reached to $210.44 billion in 2025 • Expected to grow to $342.1 billion in 2030 at a compound annual growth rate (CAGR) of 10.1% • Growth Driver: Rising Cancer Prevalence Driving Growth Of The Market Due To Aging Population And Growing Treatment Needs • Market Trend: Dr. Reddy’s Launches India’s First Immuno-Oncology Drug For Nasopharyngeal Cancer • North America was the largest region in 2025 and Asia-Pacific is the fastest growing region.

What Is Covered Under Cancer Therapy Market?

Cancer therapy refers to the treatment used to eliminate or control cancer cells in the body. It includes various approaches such as surgery, chemotherapy, radiation therapy, immunotherapy, and targeted therapy. The choice of treatment depends on the type, stage, and location of the cancer, as well as the patient's overall health. The main types of cancer therapy include chemotherapy, targeted therapy, immunotherapy, radiotherapy, and others. Chemotherapy is a type of cancer treatment that uses powerful drugs to kill or stop the growth of rapidly dividing cancer cells in the body. It is used for various cancer types such as blood cancer, breast cancer, prostate cancer, gastrointestinal cancer, gynecologic cancer, respiratory or lung cancer, and other cancer types and is used by several end users such as hospitals, specialty clinics, and cancer and radiation therapy centers.

What Is The Cancer Therapy Market Growth Forecast?

The cancer therapy market size is expected to see rapid growth in the next few years. It will grow to $342.1 billion in 2030 at a compound annual growth rate (CAGR) of 10.1%. The growth in the forecast period can be attributed to biomarker-driven therapies, immuno-oncology pipeline growth, precision medicine adoption, rising healthcare expenditure, early cancer detection. Major trends in the forecast period include rapid adoption of immunotherapy, growth of targeted cancer treatments, expansion of precision oncology, increasing use of combination therapies, shift toward personalized treatment protocols.

Global Cancer Therapy Market Segmentation

1) By Therapy Type: Chemotherapy, Target Therapy, Immunotherapy, Radiotherapy, Other Therapy Types 2) By Cancer Type: Blood Cancer, Breast Cancer, Prostate Cancer, Gastrointestinal Cancer, Gynaecologic Cancer, Respiratory Or Lung Cancer, Other Cancer Types 3) By End User: Hospitals, Specialty Clinics, Cancer And Radiation Therapy Centers Subsegments: 1) By Chemotherapy: Alkylating Agents, Antimetabolites, Anti-Tumor Antibiotics, Topoisomerase Inhibitors, Mitotic Inhibitors, Corticosteroids, Other Chemotherapy Drugs 2) By Targeted Therapy: Monoclonal Antibodies, Tyrosine Kinase Inhibitors (TKIs), mTOR Inhibitors, Proteasome Inhibitors, PARP Inhibitors, Other Targeted Agents 3) By Immunotherapy: Immune Checkpoint Inhibitors, CAR T-cell Therapy, Cancer Vaccines, Cytokines, Oncolytic Virus Therapy, Other Immunotherapies 4) By Radiotherapy: External Beam Radiation Therapy (EBRT), Internal Radiation Therapy (Brachytherapy), Systemic Radiation Therapy, Stereotactic Radiosurgery (SRS), Intensity-Modulated Radiation Therapy (IMRT), Image-Guided Radiation Therapy (IGRT) 5) By Other Therapy Types: Hormone Therapy, Stem Cell Transplant, Photodynamic Therapy, Cryoablation, Hyperthermia Therapy

What Is The Driver Of The Cancer Therapy Market?

The increasing prevalence of cancer is expected to propel the growth of the cancer therapy market going forward. Cancer refers to a group of diseases characterized by the uncontrolled growth and spread of abnormal cells in the body. Cancer is rising primarily due to increasing exposure to environmental carcinogens such as pollution and tobacco smoke. Cancer therapy plays a crucial role in managing the rising prevalence of cancer by treating existing cases, improving survival rates, and reducing disease progression. For instance, in February 2024, according to the World Health Organization (WHO), a Switzerland-based intergovernmental organization, global cancer incidence is expected to reach over 35 million new cases by 2050, representing a 77% increase from the estimated 20 million cases recorded in 2022. Therefore, the increasing prevalence of cancer is driving the cancer therapy industry.

Key Players In The Global Cancer Therapy Market

Major companies operating in the cancer therapy market are Pfizer Inc., Johnson & Johnson, F. Hoffmann-La Roche Ltd, Merck & Co. Inc., Bayer Aktiengesellschaft, Bristol-Myers Squibb Company, AstraZeneca PLC, Novartis International AG, GlaxoSmithKline PLC, Elekta AB, Exelixis Inc., Accuray Incorporated, Akeso Inc., Nanobiotix S.A., SOTIO Biotech a.s., AdvanCell Isotopes Pty Ltd, Axcynsis Therapeutics Pte Ltd, Clarity Pharmaceuticals Ltd, Affimed N.V., Aptadel Therapeutics S.L.

Global Cancer Therapy Market Trends and Insights

Major companies operating in the cancer therapy market are focusing on developing innovative therapies, such as immuno-oncology drugs, to enhance treatment effectiveness by harnessing the body's immune system to target and destroy cancer cells. Immuno-oncology drugs are a class of cancer treatments that stimulate or enhance the body’s own immune system to recognize and attack cancer cells more effectively. For instance, in December 2024, Dr. Reddy’s Laboratories Ltd., an India-based pharmaceutical company, introduced Toripalimab, the first and only immuno-oncology medication authorized for the treatment of nasopharyngeal cancer, in India. This launch brings a new, targeted treatment option for patients suffering from this rare and aggressive cancer, potentially improving outcomes through advanced immune system engagement. The availability of toripalimab in India underscores Dr. Reddy’s commitment to expanding access to cutting-edge cancer therapies in underserved areas.

What Are Latest Mergers And Acquisitions In The Cancer Therapy Market?

In December 2023, Pfizer Inc., a US-based pharmaceutical company, acquired Seagen Inc. for $43 billion. With this acquisition, Pfizer aims to strengthen its oncology portfolio by integrating Seagen’s advanced ADC technology for more precise cancer treatments. Seagen Inc. is a US-based company focused on developing ADCs that precisely target cancer cells while minimizing harm to healthy tissue.

Regional Insights

North America was the largest region in the cancer therapy market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in this market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in this market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

What Defines the Cancer Therapy Market?

The cancer therapy market includes revenues earned by entities by providing services such as hormone therapy, stem cell transplant, cryoablation, and photodynamic therapy. The market value includes the value of related goods sold by the service provider or included within the service offering. Only goods and services traded between entities or sold to end consumers are included.

How is Market Value Defined and Measured?

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified). The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

What Key Data and Analysis Are Included in the Cancer Therapy Market Report 2026?

The cancer therapy market research report is one of a series of new reports from The Business Research Company that provides market statistics, including industry global market size, regional shares, competitors with the market share, detailed market segments, market trends and opportunities, and any further data you may need to thrive in the cancer therapy industry. The market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future state of the industry.